Login

HilleVax, Inc. 4 SEC Filings

Filed On Filing
19 Sep 2025 Form 4: Takeda Pharmaceutical Co Ltd, 10% owner and 1 other

Disposed of 6,724,000 shares (Tender Offer) ($13.1M)

17 Sep 2025 Form 4: Frazier Life Sciences X, L.p., 10% owner and 4 others

Disposed of 8,552,536 shares (Tender Offer) ($16.7M)

17 Sep 2025 Form 4: Hershberg Robert, Director

Disposed of 1,101,498 shares (Tender Offer)

17 Sep 2025 Form 4: Cocero Nanette, Director

Disposed of 17,199 shares (Tender Offer)

17 Sep 2025 Form 4: Hilleman Jeryl L, Director

Disposed of 59,224 shares (Tender Offer)

17 Sep 2025 Form 4: Chu Shelley, Director

Disposed of 17,199 shares (Tender Offer)

17 Sep 2025 Form 4: Dubin Gary, Director

Disposed of 17,199 shares (Tender Offer)

17 Sep 2025 Form 4: Kohli Aditya, Director

Disposed of 698,171 shares (Tender Offer)

17 Sep 2025 Form 4: Gerberding Julie L., Director

Disposed of 59,224 shares (Tender Offer)

17 Sep 2025 Form 4: Sepulveda Jaime, Director

Disposed of 59,224 shares (Tender Offer)

17 Sep 2025 Form 4: Maltbie Shane, Chief Financial Officer

Disposed of 83,738 shares (Tender Offer)

25 Jun 2025 Form 4: Heron Patrick J, Director

Received 17,199 shares as a grant or award

25 Jun 2025 Form 4: Kohli Aditya, Director

Received 17,199 shares as a grant or award

25 Jun 2025 Form 4: Chu Shelley, Director

Received 17,199 shares as a grant or award

25 Jun 2025 Form 4: Sepulveda Jaime, Director

Received 17,199 shares as a grant or award

25 Jun 2025 Form 4: Cocero Nanette, Director

Received 17,199 shares as a grant or award

25 Jun 2025 Form 4: Gerberding Julie L., Director

Received 17,199 shares as a grant or award

25 Jun 2025 Form 4: Dubin Gary, Director

Received 17,199 shares as a grant or award

25 Jun 2025 Form 4: Hilleman Jeryl L, Director

Received 17,199 shares as a grant or award

30 Apr 2025 Form 4: Chu Shelley, Director

Granted 22,500 Stock Option

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support